Short Interest in YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Drops By 56.7%

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) saw a large drop in short interest in August. As of August 14th, there was short interest totaling 67,120 shares, a drop of 56.7% from the July 30th total of 154,895 shares. Based on an average daily trading volume, of 111,339 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.9% of the shares of the company are short sold.

YieldMax MRNA Option Income Strategy ETF Price Performance

NYSEARCA:MRNY traded down $0.77 during mid-day trading on Friday, reaching $32.62. The company’s stock had a trading volume of 194,622 shares, compared to its average volume of 238,141. The firm’s fifty day moving average price is $19.81 and its two-hundred day moving average price is $18.44. YieldMax MRNA Option Income Strategy ETF has a 12-month low of $13.60 and a 12-month high of $42.39.

YieldMax MRNA Option Income Strategy ETF Company Profile

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.